Dosimetric and hematological toxicity analyses of bone marrow‐sparing intensity‐modulated radiation therapy for patients with cervical cancer treated with extended‐field radiation therapy

Documenti analoghi

• Comments on “On the significance of peak dose in normal tissue toxicity in spatially fractionated radiotherapy: The case of proton minibeam radiation therapy”
  di: Zhaoning Wang, et al.
  Pubblicazione: (2025)
• Boron‐10 carriers and their applications in boron neutron capture therapy
  di: Dachao Tang, et al.
  Pubblicazione: (2026)
• Revolutionizing cancer treatment: The role of radiopharmaceuticals in modern cancer therapy
  di: Treesa P. Varghese, et al.
  Pubblicazione: (2024)
• Fast microdosimetry algorithms in particle therapy: Benchmark and applicability guidelines
  di: Giorgio Cartechini, et al.
  Pubblicazione: (2026)
• Experimental design and control methods for dose rate optimization in a synchrotron‐based proton therapy beamline
  di: Jason Tang, et al.
  Pubblicazione: (2025)